PFM Health Sciences’s Groupon GRPN Stock Holding History

PFM Health Sciences’s Portfolio GRPN Stock Details GRPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-97,196	Closed	-$10M	–	103
2016 Q3	$10M	Buy	+97,196	New	+$9.47M	0.29%	73

Other funds holding GRPN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences's GRPN Position: Q4 2016 in Review

PFM Health Sciences sold out of Groupon (GRPN) in Q4 2016, closing a stake of 97,196 shares — an estimated $10M sold.

PFM Health Sciences first reported a position in GRPN in Q3 2016 and held it in 1 quarter. The position peaked at $10M in Q3 2016. 192 funds tracked by Wall St. Rank hold GRPN as of Q4 2016.

PFM Health Sciences reported no remaining Groupon position as of Q4 2016 after selling out during the quarter.
PFM Health Sciences sold 97,196 Groupon shares in Q4 2016, an estimated $10M.
PFM Health Sciences first reported a position in Groupon in Q3 2016 and held it in 1 quarter.
PFM Health Sciences's Groupon position peaked at $10M in Q3 2016.
192 funds tracked by Wall St. Rank held Groupon as of Q4 2016.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.